Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

BACKGROUND: Dexamethasone was the first intervention proven to reduce mortality in patients with COVID-19 being treated in hospital. We aimed to evaluate the adoption of corticosteroids in the treatment of COVID-19 in the UK after the RECOVERY trial publication on June 16, 2020, and to identify disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Närhi, Fiina, Moonesinghe, S Ramani, Shenkin, Susan D, Drake, Thomas M, Mulholland, Rachel H, Donegan, Cara, Dunning, Jake, Fairfield, Cameron J, Girvan, Michelle, Hardwick, Hayley E, Ho, Antonia, Leeming, Gary, Nguyen-Van-Tam, Jonathan S, Pius, Riinu, Russell, Clark D, Shaw, Catherine A, Spencer, Rebecca G, Turtle, Lance, Openshaw, Peter J M, Baillie, J Kenneth, Harrison, Ewen M, Semple, Malcolm G, Docherty, Annemarie B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940185/
https://www.ncbi.nlm.nih.gov/pubmed/35337642
http://dx.doi.org/10.1016/S2589-7500(22)00018-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940185/
https://www.ncbi.nlm.nih.gov/pubmed/35337642
http://dx.doi.org/10.1016/S2589-7500(22)00018-8

Ejemplares similares